Summit Trail Advisors LLC Invests $345,000 in Avantor, Inc. (NYSE:AVTR)

Summit Trail Advisors LLC purchased a new stake in Avantor, Inc. (NYSE:AVTR - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 21,259 shares of the company's stock, valued at approximately $345,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Peregrine Capital Management LLC increased its position in shares of Avantor by 11.4% during the first quarter. Peregrine Capital Management LLC now owns 955,136 shares of the company's stock worth $15,483,000 after purchasing an additional 97,598 shares in the last quarter. New York State Teachers Retirement System boosted its position in shares of Avantor by 1.7% in the 1st quarter. New York State Teachers Retirement System now owns 343,022 shares of the company's stock valued at $5,560,000 after purchasing an additional 5,671 shares during the period. KBC Group NV grew its stake in Avantor by 483.7% during the 1st quarter. KBC Group NV now owns 1,823,686 shares of the company's stock worth $29,562,000 after buying an additional 1,511,255 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its position in Avantor by 3.0% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,544,434 shares of the company's stock worth $25,035,000 after buying an additional 45,531 shares during the period. Finally, Transcend Capital Advisors LLC acquired a new position in Avantor during the first quarter worth approximately $303,000. Institutional investors and hedge funds own 95.08% of the company's stock.

Avantor Stock Performance

Shares of AVTR stock traded down $0.01 during mid-day trading on Friday, hitting $13.88. The stock had a trading volume of 6,225,578 shares, compared to its average volume of 8,407,448. The firm has a market cap of $9.46 billion, a PE ratio of 13.35, a PEG ratio of 1.47 and a beta of 1.05. The company's 50-day simple moving average is $13.13 and its 200-day simple moving average is $16.61. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.12 and a quick ratio of 0.75. Avantor, Inc. has a fifty-two week low of $11.82 and a fifty-two week high of $28.00.

Avantor (NYSE:AVTR - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.23 EPS for the quarter, meeting analysts' consensus estimates of $0.23. Avantor had a net margin of 10.70% and a return on equity of 11.93%. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.61 billion. During the same quarter last year, the firm earned $0.22 earnings per share. The firm's revenue was down 5.9% compared to the same quarter last year. Sell-side analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current year.

Insider Activity at Avantor

In other Avantor news, Director Joseph R. Massaro purchased 8,100 shares of the firm's stock in a transaction that occurred on Tuesday, April 29th. The shares were purchased at an average cost of $12.30 per share, for a total transaction of $99,630.00. Following the completion of the purchase, the director directly owned 35,038 shares in the company, valued at $430,967.40. This represents a 30.07% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Gregory L. Summe acquired 30,000 shares of the business's stock in a transaction on Friday, May 23rd. The stock was acquired at an average price of $12.50 per share, with a total value of $375,000.00. Following the transaction, the director directly owned 100,000 shares of the company's stock, valued at $1,250,000. This represents a 42.86% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 83,100 shares of company stock valued at $1,027,630 over the last three months. Insiders own 1.20% of the company's stock.

Wall Street Analysts Forecast Growth

AVTR has been the subject of a number of research reports. Morgan Stanley cut Avantor from an "overweight" rating to an "equal weight" rating in a research note on Tuesday, April 29th. Barclays reduced their price target on shares of Avantor from $18.00 to $15.00 and set an "overweight" rating for the company in a research report on Monday, April 28th. Stifel Nicolaus downgraded shares of Avantor from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $26.00 to $14.00 in a research report on Monday, April 28th. Cowen lowered shares of Avantor from a "buy" rating to a "hold" rating in a research note on Monday, April 28th. Finally, TD Cowen downgraded shares of Avantor from a "buy" rating to a "hold" rating and set a $15.50 target price for the company. in a research note on Monday, April 28th. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $18.14.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.